Hypertension caused by chronic intermittent hypoxia - Influence of chemoreceptors and sympathetic nervous system

Journal of Hypertension

Volumn 15, Issue 12 II, 1997, Pages 1593-1603

  Leßke, Joachim ^a   Fletcher, Eugene C ^b   Bao, Gang ^b   Unger, Thomas ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemoreceptors; Heart hypertrophy; Hypertension; Intermittent hypoxia; Review; Sleep apnea syndrome; Sympathetic nervous system

Indexed keywords

OXIDOPAMINE;

ADRENAL MEDULLECTOMY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; CHEMORECEPTOR; CONFERENCE PAPER; DENERVATION; HYPERTENSION; HYPOXIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SLEEP APNEA SYNDROME;

EID: 0031457720     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715120-00060     Document Type: Conference Paper

References (67)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S: The occurrence of sleep-disordered breathing among middle aged adults. N Engl J Med 1993, 328:1230-1235.
2. Partinen M, Palomaki H: Snoring and cerebral infarction. Lancet 1985, ii:1325-1326.
3. Koskenvuo M, Kaprio J, Telakivi K, Partinen M, Heikkala K, Sarna S: Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987, 294:16-19.
4. Guilleminault C, Tilkian A, Dement WC: The sleep apnea syndromes. Annu Rev Med 1976, 27:465-484.
5. Lavie P, Alroy G, Halpern E: Apneic and nonapneic breathing disorders in sleep. Isr J Med Sci 1982, 181:523.
6. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB: Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985, 103:190-195.
7. Kales A, Cadieux RJ, Shaw LC, Vela-Bueno A, Bixler EO, Schneck DW, et al.: Sleep apnea in a hypertensive population. Lancet 1984, ii:1005-1008.
8. Lavie P, Ben-Yosef R, Rubin AE: Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984, 108:373-376.
9. Williams AJ, Houston D, Finberg S, Lam C, Kinney JL, Santiago S: Sleep apnea syndromes and essential hypertension. Am J Cardiol 1985, 55:1019-1022.
10. Khatri IM, Freis ED: Hemodynamic changes during sleep. J Appl Physiol 1967, 22:867-873.
11. Litter WA, Honour AJ, Carter RD, Sleight P: Sleep and blood pressure. BMJ 1975, 3:346.
12. Litter WA: Sleep and blood pressure: further observations. Am Heart J 1979, 97:35-37.
13. Lugaresi E, Coccagna G, Cirignotta G, et al.: Breathing during sleep in man in normal and pathological conditions. Adv Exp Med Biol 1978, 99:35-45.
14. Lugaresi E, Coccagna G, Garneti P, Mantoviani M, Cirignotta F: Snoring. Electroenceph Clin Neurophysiol 1975, 39:59-64.
15. Coccagna C, Mantovani M, Brignani F, Parchi E, Lugaresi E: Tracheostomy in hypersomnia with periodic breathing. Bull Physiopath Resp 1972, 8:1217-1227.
16. Guilleminault C, Eldridge FL, Simmons FB, Dement WC: Sleep apnea syndrome: can it induce hemodynamic changes? West J Med 1975, 123:7-16.
17. Guilleminault C, Simmons FB, Motta J, et al.: Obstructive sleep apnea syndrome and tracheostomy. Arch Intern Med 1981, 141:987-988.
18. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T: Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 1989, 2:847-852.
19. Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, van Wichert P: Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991, 79:84-92.
20. Guilleminault C, Suzuki M: Sleep-related hemodynamics and hypertension with partial or complete upper airway obstruction during sleep. Sleep 1992, 15:20-24.
21. Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FC, Fletcher PJ, et al.: Effect of nasal continuous airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993, 16:539-544.
22. Millman R, Redline S, Carlisle CC, Assuf AR, Cevinson PD: Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991, 99:861-866.
23. Warley ARH, Mitchell AH, Stradling JR: Prevalence of nocturnal hypoxemia in men with and without hypertension. Q J Med 1988, 68:637-644.
24. Carlson JT, Hedner JA, Enjell H, Peterson LE: High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994, 150:72-77.
25. Lavie P, Yoffe N, Berger J, Peled R: The relationship between the severity of sleep apnea syndrome and 24-h blood pressure values in patients with obstructive sleep apnea. Chest 1993, 103:717-721.
26. Kiselak J, Clark M, Pera V, Rosenberg C, Redline S: The association between hypertension and sleep apnea in obese patients. Chest 1993, 104:775-780.
27. Bao G, Randhawa PM, Fletcher EC: Acute blood pressure elevation during repetitive hypocapnic and eucapnic hypoxia in rats. J Appl Physiol 1997, 82:1071-1078.
28. Martin-Body RL, Robson GJ, Sinclair JD: Respiratory effects of sectioning the carotid sinus glossopharyngeal and abdominal vagal nerves in awake rat. J Physiol Lond 1985, 361:35-45.
29. Kostrzewa RM, Jacobowitz DM: Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 1974, 26:199-288.
30. Kaufman LN, Li H, Peterson MM, Gilardy AK: Adrenal medulla as a mediator of diet induced hypertension. Am J Physiol 1993, 238:R1-R6.
31. Goldstein DS, Feuerstein G, Izzo JL, Kopia IJ: Liquid chromatography for measuring norepinephrine, and epinephrine in man. Life Sci 1981, 28:467-475.
32. Da Prada M: Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline, and dopamine with the femtomole range. Life Sci 1976, 19:1161-1174.
33. Keller RA, Oke A, Mefford I, Adams RN: Liquid chromatographic analysis of catecholamines: routine assay for regional mapping. Life Sci 1976, 19:995-1004.
34. Anton AH, Sayre DF: A study of the factors affecting the aluminium oxide trihydroxyindole procedure for analysis of catecholamines. J Pharmacol Exp Ther 1962, 138:360-374.
35. Torda T, Culman J, Petrikova M: Distribution of phenylethanolamine-N-methyltransferase in the rat heart: effect of 6-hydroxydopamine. Eur J Pharmacol 1987, 141:305-308.
36. Fletcher EC, Leßke J, Qian W, Miller CC, Unger Th: Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992, 19:555-561.
37. Fletcher EC, Gang B, Miller CC: Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. J Appl Physiol 1995, 78:1516-1521.
38. Fletcher EC, Leßke J, Behm R, Miller CC, Stauss H, Unger Th: Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 1992, 72:1978-1984.
39. Leßke J, Fletcher EC, Behm R, Miller CC, Stauss H, Unger Th: Systemische Blutdruckerhöhung als Reaktion auf chronische intermittierende Hypoxie wird durch Carotiskörperdenervation verhindert. Nieren- und Hochdruckkrankheiten 1992, 21:652-653.
40. Fletcher EC, Lesske J, Culman J, Miller CC, Unger Th: Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 1992, 20:612-619.
41. Leßke J, Fletcher EC, Culman J, Miller CC, Unger Th: Die Rolle des peripheren sympathischen Nervensystems für die Blutdruckerhöhung bei chronisch intermittierender Hypoxie. Nieren- und Hochdruckkrankheiten 1993, 22:308-316.
42. Bao G, Metreveli N, Li R, Taylor A, Fletcher EC: Blood pressure response to chronic episodic hypoxia: role of sympathetic nervous system. J Appl Physiol 1997, 83:95-101.
43. Fletcher EC, Bao G: Effect of eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension-prone rats. J Appl Physiol 1996, 81:2088-2094.
44. Ou LC, Smith RP: Probable strain differences of rats in susceptibilities and cardiopulmonary responses to chronic hypoxia. Resp Physiol 1983, 53:367-377.
45. Lund DD, Tomanek RJ: The effects of chronic hypoxia on the myocardial cell of normotensive and hypertensive rats. Anat Rec 1980, 196:421-430.
46. Hedner J, Ejnell H, Caidahl K: Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990, 8:941-946.
47. Shepard JW Jr: Gas exchange and hemodynamics during sleep. Med Clin North Am 1985, 69:1243-1263.
48. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA: Obstructive sleep apnea as a cause of systemic hypertension. Evidence of a canine model. J Clin Invest 1997, 99:106-109.
49. Alford NJ, Reicher EC, Nickeson D: Effects of acute oxygen in patients with sleep apnea and COPD. Chest 1986, 89:30-38.
50. Somers VK, Zavala A, Mark AL, Abboud FM: Sympathetic nerve response to hypoxia during breathing and apnea in normal humans [abstract]. Circulation 1987, 76 (suppl 4):48.
51. Mitchell RA, Loeschke HH, Severinghaus JW, Richardson BW, Massion WH: Regions of respiratory chemosensitivity on the surface of medulla. Ann NY Acad Sci 1963, 109:661.
52. o2. J Appl Physiol 1973, 35:903-913.
53. Sapru H, Krieger AJ: Carotid and aortic chemoreceptor function in the rat. J Appl Physiol 1977, 42:344-348.
54. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G: Is high and fluctuating muscle nerve sympathetic activity in the sleep apnea syndrome pathogenetically important for the development of hypertension? J Hypertens 1988, 6 (suppl 4):529-531.
55. Morgan BJ, Crabtree DC, Palta M, Skatrud J: Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 1995, 79:205-213.
56. Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
57. Rose CE Jr, Althaus JA, Kaiser DL, Miller ED, Carey RM: Acute hypoxemia and hypercapnia: increase in plasma catecholamines in conscious dogs. Am J Physiol 1983, 245:H924-H919.
58. Fletcher EC, Miller J, Schaaf JW, Reicher JG: Urinary catecholamines before and after trachestomy in patients with obstructive sleep apnea and hypertension. Sleep 1987, 10:35-44.
59. Floras JS, Aylward PE, Mark AL, Abboud FM: Adrenalin facilitates neurogenic vasoconstriction in borderline hypertensive subjects. J Hypertens 1990, 8:443-448.
60. Floras JS, Aylward PE, Victor RG, Mark AL, Abboud FM: Epinephrine facilitates neurogenic vasoconstriction in humans. Clin Invest 1988, 81:1265-1274.
61. Henley WN, Tucker A: Hypoxic moderation of systemic hypertension in the spontaneously hypertensive rat. Am J Physiol 1987, 252:R554-R561.
62. Fregly MJ: Effect of chronic exposure to hypoxia on development and maintenance of renal hypertension in rats. Proc Soc Exp Biol Med 1970, 134:78-82.
63. Loeffler JR, Stockigt JR, Ganong WF: Effect of alpha and beta adrenergic blocking agents on the increase in renin secretion by stimulation of renal nerves. Neuroendocrinology 1972, 10:129-138.
64. Somers VK, Dyken ME, Mark AL, Abboud FM: Sympathetic nerve activity during sleep in normal subjects. N Engl J Med 1993, 328:303-307.
65. Lofaso F, Coste A, Gilian L, Harf A, Guilleminault C, Goldenberg F: Sleep fragmentation as a risk factor for hypertension in middle-aged nonapneic snorers. Chest 1996, 109:896-900.
66. Somers VK, Zavala DC, Mark AL, Abboud FM: Influence of ventilation and hypocapnia on sympathetic nerve response to hypoxia in normal humans. J Appl Physiol 1989, 67:2095-2100.
67. Somers VK, Mark AL, Zavala DC, Abboud FM: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989, 67:2101-2106.